NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, ...

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc.  (“Hims & Hers” or the “Company”) (NYSE: HIMS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Hims & Hers and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class actio ...

Core Viewpoint - Nvidia is currently a leader in the AI sector, but there is a possibility that Wall Street is underestimating its software advantages, data center expansion, and edge AI initiatives, unless faced with increasing competition or overvaluation concerns [1] Group 1: Software Moat - Nvidia's software moat is a significant factor that may not be fully recognized by investors, providing a competitive edge in the AI market [1] Group 2: Data Center Growth - The company is experiencing substantial growth in its data center segment, which is a critical driver of its overall business performance [1] Group 3: Edge AI Ambitions - Nvidia has ambitious plans for edge AI, which could further enhance its market position and growth potential in the coming years [1] Group 4: Market Risks - The potential for rising competitors and concerns about overvaluation could pose risks to Nvidia's continued success in the market [1]

Group 1 - Apogee Enterprises (APOG) is expected to experience revenue and margin improvement, with sales gaining momentum in the latter half of fiscal 2026 [1] - The anticipated growth is supported by a rebound in the Metals segment, improving trends in Glass, and solid organic demand [1]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving KBR, Inc. and its officers or directors following a significant stock price drop due to the termination of a key contract [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of KBR, Inc. and is looking into claims of securities fraud or other unlawful business practices [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the investigation [1]. Group 2: Stock Performance - On June 20, 2025, KBR announced that HomeSafe Alliance, a joint venture, had its role in the Global Household Goods Contract terminated by U.S. Transportation Command [3]. - Following this announcement, KBR's stock price decreased by $3.85 per share, representing a 7.29% decline, closing at $48.93 per share [3].

Group 1 - The satellite business is currently the hottest trend, with many space companies competing to establish dominance in the market [1] - SpaceX, led by Elon Musk, is the most discussed company in the satellite sector, particularly due to its heavy-lift Starship [1]

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nike. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

Core Insights - The focus is on finding value in investments, particularly through purchasing undervalued assets at a significant discount [1] - There is an openness to international investments, including both mainstream and frontier markets [1] Group 1 - The investment strategy emphasizes acquiring assets for less than their intrinsic value, aiming for a margin of safety [1] - The individual expresses admiration for renowned investors Benjamin Graham and Walter Schloss, indicating a value investing philosophy [1] - The intention to share equity analysis and investment insights suggests a commitment to transparency and knowledge dissemination [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Organon & Co. securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the Organon securities lawsuit is from October 31, 2024, to April 30, 2025, inclusive [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A lead plaintiff must file a motion with the court by July 22, 2025, to represent other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Organon's defendants made misleading statements while concealing material adverse facts about the company's capital allocation priorities [4]. - Specifically, the lawsuit claims that the defendants concealed the importance of debt reduction following the acquisition of Dermavant, which led to a 70% decrease in the regular quarterly dividend [4]. - Investors reportedly suffered damages when the true details about the company's financial priorities became public [4].

Group 1: Smith & Wesson Brands - Smith & Wesson Brands is currently trading at $8.66, with a 52-week range of $8.38 to $16.85 and a dividend yield of 6.00% [2] - The company faces significant headwinds, including tariffs and revenue deleveraging, which have negatively impacted margins and led to insufficient income to cover the dividend [2][3] - The payout ratio is projected to exceed 150% by the end of fiscal 2025, raising concerns about the sustainability of the dividend [2][3] - Analysts have a consensus rating of Moderate Buy, but sentiment is declining, and the price target is falling, indicating potential further downside risk [4] Group 2: SunCoke Energy - SunCoke Energy is trading at $8.18, with a 52-week range of $7.47 to $12.82 and a dividend yield of 5.86% [6] - The company has headwinds from weaker coal prices; however, its dividend payment is considered safe due to long-term contracts that guarantee cash flow [6][7] - The payout ratio is expected to be around 70% in 2025, which is sustainable for the business [6] - A recent acquisition of Phoenix Global is anticipated to positively impact revenue and profitability, diversifying SunCoke's business [7] - MarketBeat tracks one analyst rating this stock as a Buy, with a price target over 65% above current trading levels, supported by strong institutional ownership [8] Group 3: Tronox Holdings - Tronox Holdings is trading at $5.67, with a 52-week range of $4.35 to $17.45 and a dividend yield of 8.82% [10] - The company reported a net loss for the previous fiscal year, but analysts believe it is at a turning point due to shifts in demand for TiO2 pigments [10][12] - The consensus rating among eight analysts is Moderate Buy, indicating potential for a 50% upside, with recent upgrades from JPMorgan raising the price target to $7 [11] - Tronox's balance sheet is strong enough to sustain the dividend until business conditions improve, with expectations of positive earnings by the end of the fiscal year [12]